STS Administration on Coronavirus Disease (COVID-19) Patients in Critical Care
Status:
Recruiting
Trial end date:
2023-02-28
Target enrollment:
Participant gender:
Summary
The primary purpose is to describe the safety of administration of three doses of STS to
critically ill patients with confirmed COVID-19. A secondary purpose is to describe data on
the clinical efficacy of administration of up to three doses of STS in critically ill
patients with confirmed COVID-19.